Opemalirsen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Opemalirsen, covering 2026-02-24 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373) [Phase 1]